2/4/2024 | 29335990 | PHARMACEUTICAL RESEARCH MATERIAL (FME066) | NOVARTIS PHARMA AG (BASEL) | 1.6 | GMS | 13.02 | SWITZERLAND | HYDERABAD AIR |
2/4/2024 | 29335990 | PHARMACEUTICAL RESEARCH MATERIAL (FME066) | NOVARTIS PHARMA AG (BASEL) | 1.32 | GMS | 13.02 | SWITZERLAND | HYDERABAD AIR |
2/4/2024 | 29335990 | PHARMACEUTICAL RESEARCH MATERIAL (FME066) | NOVARTIS PHARMA AG (BASEL) | 1.39 | GMS | 13.02 | SWITZERLAND | HYDERABAD AIR |
2/4/2024 | 29335990 | PHARMACEUTICAL RESEARCH MATERIAL (FME066) | NOVARTIS PHARMA AG (BASEL) | 7.5 | GMS | 17.76 | SWITZERLAND | HYDERABAD AIR |
2/4/2024 | 29335990 | PHARMACEUTICAL RESEARCH MATERIAL (FME066) | NOVARTIS PHARMA AG (BASEL) | 3.08 | GMS | 14.21 | SWITZERLAND | HYDERABAD AIR |
12/19/2023 | 29335990 | PEMETREXED DISODIUM (QTY: 1 X 100 MG, VALUE: USD 273) (FOC) 29 | USP | 0 | KGS | 286.6 | SWITZERLAND | HYDERABAD AIR |
11/27/2023 | 29335990 | SINCALIDE (FOC) | M/S. MAIA PHARMACEUTICALS,INC | 2 | GMS | 202.07 | SWITZERLAND | HYDERABAD ACC |
11/24/2023 | 29335990 | MGY825 DRUG SUBSTANCE SAMPLE SOLID, 1. G PER ITEM | M/S. NOVARTIS PHARMA AG (BASEL) | 42 | PCS | 1065.68 | SWITZERLAND | HYDERABAD ACC |
11/24/2023 | 29335990 | MGY825 DRUG SUBSTANCE SAMPLE SOLID, 1.G PER ITEM | M/S. NOVARTIS PHARMA AG (BASEL) | 14 | PCS | 355.23 | SWITZERLAND | HYDERABAD ACC |
11/4/2023 | 29335990 | KAE609-NXA.004 DRUG SUBSTANCE | M/S.NOVARTIS PHARMA AG (BASEL) | 600 | GMS | 1410.41 | SWITZERLAND | HYDERABAD ACC |